BrandPilot AI Inc. announced that it has created an Advisory Board to advise management and the Board of Directors on the strategic development of the business, opportunities for investment, and the development of its mobile and web applications. Bart Piwowar, Cameron Battley, and Marc Lakmaaker, a former director of the Company, have been appointed as inaugural members of the Advisory Board, which the Company expects to expand in the near future. Bart is an experienced product executive and startup operator with over 15 years of experience in product management, building product teams and working closely with customers.

He was a Director for CIBC's Data Studio Innovation Lab and a technical lead at Deloitte's Innovation Lab. Bart has a track record for finding Product Market Fit, bringing sophisticated AI products to market (GTM), as well as scaling more mature products. More recently, Bart was a VP of Product at both Primal AI and Darwin AI.

Bart, along with the BrandPilot AI CRO John Beresford, co-founder of Socialpeeks, one of Canada's oldest influencer marketing technology companies has in- depth knowledge in SaaS business models and Enterprise solution delivery, with a core strength in AI and data centric products. His technical competencies in AI include: Machine Vision, GenAI & LLMs, agent systems. Cam has more than 25 years experience as an executive in the global cannabis and biopharmaceutical industries. He was an equity partner and director of medical cannabis company MedReleaf Australia from 2019 until its sale to Aurora Cannabis in 2024.

He earlier served as Senior VP, Executive VP, then Chief Corporate Officer for Aurora, as well as in executive roles for Canopy Growth Corporation and Bedrocan Canada. He was elected a member of the board of directors of the Canadian Medical Cannabis Industry Association (later Cannabis Council of Canada). Cam began his pharmaceutical career with Eli Lilly, and founded Health Strategy Group Inc., a management consultancy working with leading health care companies in North America, Europe, Asia and Africa.

He has been a director of the patient advocacy group Campaigning for Cancer (South Africa) since 2007. Marc is an accomplished capital markets veteran with 25 years of experience in IR, corporate communication and development, as well as sales and marketing. Having assisted a diverse portfolio of companies, from tiny micro- cap to bulge bracket blue chip firms, in achieving their corporate and capital markets objectives, Marc leverages his deep and diverse background to create outsized value.

The founder of AdvanceCap, a boutique capital markets advisory firm, Marc is able to mobilize a global network to help his clients accelerate growth, create value and pursue unique opportunities.